Inhibition of sphingolipid metabolism in osteosarcoma protects against CD151-mediated tumorigenicityHongsheng Wang(Sun Yat-sen University), Wei Sun(Shanghai Jiao Tong University)Cell & BioscienceOctober 8, 202210.1186/s13578-022-00900-9Cited by 8SaveCiteExport RISWatch citationsRelated PapersReprogramming tumor microenvironment via dual targeting co-delivery of regorafenib and alpha-difluoromethylornithine in osteosarcoma|Cancer Nanotechnology|2023|6